University of Michigan Health System - link
Department of Internal Medicine - link
RHEUMATOLOGY
search this site
 

About Us



Info for Patients




Referring Physicians




Our Faculty




Education & Research



More News




Internal Resources




Internal Medicine Divisions

 
Our Faculty
Joseph Holoshitz, M.D.
 
Faculty Appointment: Professor, Department of Internal Medicine
Additional Title: Associate Chief, Research Activities
Specialty: Rheumatology
Clinical Interests: Inflammatory arthritis.
Research Interests: The research theme of Dr. Holoshitz' laboratory is the role of signal transduction events in health and disease. Using cellular, molecular, signal transduction and protein chemistry strategies, the laboratory is focusing on three research projects: 1. We have recently discovered that the rheumatoid arthritis (RA) shared epitope (SE) is capable of altering important signaling events. The cell surface receptor of the SE has been identified. We are presently characterizing the intracellular events that the SE triggers and deciphering the structure/function requirements of ligand-receptor interaction, using empiric and combinatorial peptide design approaches as well as mutational analysis of the binding domain(s) on the receptor. In a related project, the effect of the SE on endothelial and dendritic cells activation and differentiation is being studied. Beyond their potential utility for understanding immune mechanisms in RA, these studies could provide new insights into MHC-disease association. 2. The second project involves non-peptidic phosphoantigens, which activate a subset of T cells, called gamma-delta T cells. We have made progress in understanding the signaling pathway triggered by these compounds. We are currently investigating the effect of phosphoantigens on the cytolytic activity of gamma-delta T cells and the mechanisms involved in attenuation of that activity with SE ligands. 3. The focus of the third project is aberrations in program cell death (apoptosis) signaling in RA. We have identified a pathway that aberrantly attenuates apoptotic signals in lymphocytes and synovial fibroblasts from patients with RA. We are currently focusing on a family of G protein coupled receptors, which transduce the aberrant signal. In addition, proteome and microarray gene expression analyses are being employed to identify gene and protein expression patterns of RA lymphocytes in response to activation of these G protein-coupled receptors.
Degree: M.D., 1981, Hebrew University, Jerusalem
Languages other than English: Hebrew
Residency: Internal Medicine, 1981-1984
Fellowship: Rheumatology, 1989, Stanford University
Certifications: 2000, Internal Medicine
2002, Rheumatology
Faculty Appointment Date: 10/26/1989
Academic office address Medical Science Research Building I
1150 West Medical Center Drive
Room 5520
Ann Arbor, MI 48109-5680
Academic office telephone: (734)936-7905
Academic office FAX: (734)763-4151
 
 
   
   

U-M Medical School
| M-CARE | Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright 2014 Regents of the University of Michigan
Developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

U.S. News and World Reports: America's Best Hospitals 2007
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement